meningococcal disease
FDA Approves Penmenvy, GSK’s 5-in-1 Meningococcal Vaccine
The FDA approved a new 5-in-1 meningococcal vaccine for people from 10 through 25 years of age. The vaccine targets ...
FEBRUARY 18, 2025
Meningococcal Cases Increasing in U.S.
Although meningococcal disease incidence in the United States declined dramatically between 1996 and 2021, there ...
SEPTEMBER 19, 2024
Meningococcal Disease Tied to Travel for Umrah Pilgrimage
Twelve cases of meningococcal disease have been identified in travelers or their household contacts who went to ...
JULY 15, 2024
CDC Offers Guidance for Abx Prophylaxis for Resistant Meningococcal Disease
In response to rising rates of meningococcal disease cases caused by ciprofloxacin-resistant strains ...
MARCH 26, 2024
ACIP Recommends New Penbraya Vaccine Be Added to Vaccine Schedule
The CDC’s ACIP recommended the addition of the recently approved pentavalent meningococcal vaccine to the ...
OCTOBER 25, 2023
